Cargando…
PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430159/ http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a |
_version_ | 1785090889141452800 |
---|---|
author | Djodikromo, Melissa Bekker, Charlotte Hermens, Rosella Smit, Yolba Govers, Tim van den Bemt, Bart Blijlevens, Nicole |
author_facet | Djodikromo, Melissa Bekker, Charlotte Hermens, Rosella Smit, Yolba Govers, Tim van den Bemt, Bart Blijlevens, Nicole |
author_sort | Djodikromo, Melissa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104301592023-08-17 PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA Djodikromo, Melissa Bekker, Charlotte Hermens, Rosella Smit, Yolba Govers, Tim van den Bemt, Bart Blijlevens, Nicole Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430159/ http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Djodikromo, Melissa Bekker, Charlotte Hermens, Rosella Smit, Yolba Govers, Tim van den Bemt, Bart Blijlevens, Nicole PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title | PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title_full | PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title_fullStr | PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title_full_unstemmed | PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title_short | PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA |
title_sort | pb1978: patient-centredness is pivotal in a prospective dose reduction trial of tyrosine kinase inhibitors in patients with chronic myeloid leukaemia |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430159/ http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a |
work_keys_str_mv | AT djodikromomelissa pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT bekkercharlotte pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT hermensrosella pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT smityolba pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT goverstim pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT vandenbemtbart pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia AT blijlevensnicole pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia |